Sponsored Projects Administration

Sponsors begin seeking investors to defray clinical trial costs

Published October 24, 2013 by OSP


Merck is hoping to tap a new source of funding in the shape of private equity, which has largely shunned the high-risk business that requires deep knowledge of medicine and regulatory requirements.

Read More>